HVRRY (Hannover Rueck SE) Research & Development: $0 Mil (TTM As of Mar. 2026)


HVRRY Hannover Rueck SE HVRRY
71 GF Score
Price $45.12
GF Value $60.39
Valuation Modestly Undervalued
View Full Analysis

What is Hannover Rueck SE Research & Development?

Hannover Rueck SE HVRRY +1.10% 71 Research & Development is $0 Mil as of Mar. 2026. GuruFocus rates HVRRY with a GF Score™ of 71/100 and a GF Value™ of $60.39 (Modestly Undervalued).

Research & Development is the aggregate amount of research and development expenses during the year. Hannover Rueck SE's Research & Development for the three months ended in Mar. 2026 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

Hannover Rueck SE  (OTCPK:HVRRY) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Hannover Rueck SE Research & Development Related Terms

Hannover Rueck SE Research & Development Historical Data

* Premium members only.

The historical data trend for Hannover Rueck SE's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hannover Rueck SE Research & Development Chart

Hannover Rueck SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Hannover Rueck SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HVRRY
71GF Score
Hannover Rueck SE HVRRY
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hannover Rueck SE Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Hannover Rueck SE (HVRRY) has a Research & Development of $0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Hannover Rueck SE and its competitors.
Is Hannover Rueck SE's Research & Development too high?
Hannover Rueck SE's current Research & Development is $0 Mil. Overall, Hannover Rueck SE has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hannover Rueck SE's Research & Development compare to RGA and EG?
Hannover Rueck SE's Research & Development of $0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Hannover Rueck SE and its competitors. Hannover Rueck SE's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hannover Rueck SE stock overvalued right now?
Based on GuruFocus' analysis, Hannover Rueck SE (HVRRY) is currently considered Modestly Undervalued. The stock's GF Value™ is $60.39, compared to a current price of $45.12 — trading 25.3% below its estimated fair value. The current Research & Development is $0 Mil. Hannover Rueck SE's overall GF Score™ is 71/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Hannover Rueck SE (HVRRY), the current Research & Development is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hannover Rueck SE (HVRRY) Overvalued in 2026?

Based on GuruFocus' analysis, Hannover Rueck SE stock appears to be undervalued. The current stock price of $45.12 is trading 25.3% below its estimated GF Value™ of $60.39. GuruFocus considers Hannover Rueck SE to be Modestly Undervalued.

Key valuation signals for HVRRY:

  • Research & Development: $0 Mil
  • GF Value™: $60.39 vs. price of $45.12 (25.3% below fair value)
  • GF Score™: 71/100

No single metric tells the full story. See the HVRRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hannover Rueck SE Business Description

Address Karl-Wiechert-Allee 50, Hannover, NI, DEU, 30625
Hannover Re is a reinsurance company headquartered in Hannover, Germany. Its roots go back to the 1920s when, in conjunction with the Gerling Group, Haftpflichtverband founded Eisen- und Stahl-Industrie to provide reinsurance services. In the 1960s ownership of the business was turned over to Haftpflichtverband, and Aktiengesellschaft für Transport und- Rückversicherung was founded. This was the basis of Hannover Re. The business expanded into life and health reinsurance in the 1990s, and over the next 30 years expanded beyond its core domestic market of Germany to write business internationally. Hannover sold its commercial specialty insurance business to Talanx in January 2019. Hannover was listed in the 1990s on the Frankfurt Stock Exchange.
71GF Score

Get the complete analysis for HVRRY

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$45.12
Price
$60.39
GF Value